This comprehensive study assessed the impact of minor relative changes in peptide length and sequence for the induction CD8+ T cell responses in HLA-A2.1 transgenic mice to antigens relevant to the development of gynecological cancer vaccines, based on the lead vaccine antigens HPVE7, Survivin and WT1. Here, BIRC5 is linked to female reproductive organ cancer.